The Orthopedic Splints market was valued at around US$ 1.5 billion in 2021. With a projected CAGR of 11.5% for the next ten years, the market is likely to reach a valuation of nearly US$ 4.9 billion by the end of 2032. The recent surge in the cases of osteoporosis and the increasing cohort of the geriatric populace has triggered the demand for orthopedic splints.
| Attributes | Details |
|---|---|
| Orthopedic Splints Market Size (2021A) | US$ 1.5 billion |
| Orthopedic Splints Market Size (2022E) | US$ 1.7 billion |
| Projected Market Value (2032F) | US$ 4.9 billion |
| Global Market Growth Rate (2022 to 2032) | 11.5% CAGR |
| North America Market Share (2021) | 35% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for orthopedic splints expanded at a CAGR of 10.6% from 2017 to 2021. The market growth is projected to benefit from the surge in requirements for fiberglass splints. Fiberglass splints are extensively advantageous relative to plaster splints. Aside from weighing less, they are a better option because of their increased durability and porosity.
The global Orthopedic Splints market is predicted to surge ahead at a CAGR of 11.5% and record sales worth US$ 4.9 billion by the end of 2032. USA will continue to be the largest market throughout the analysis period accounting for over US$ 1.1 billion absolute dollar opportunity in the coming 10-year epoch.
The highly accelerated increase in the number of people suffering from musculoskeletal diseases like osteoporosis and arthritis is one of the instrumental driving forces for the demand for Orthopedic Splints during the 10-year forecast epoch. Additionally, the Orthopedic Splints market is also anticipated to be advanced by the increase in the geriatric cohort of the population globally, as it will directly aid in increasing the number of patients having orthopedic ailments leading to a positive impact on the orthopedic splints demand. Taking into account, a 2020 report by the National Natural Science Foundation Council of China, cases of knee osteoarthritis around the world are 16%, which is significantly more in the aged 40 and above population. Factors such as growing sports-related injuries and the increase in the number of road accidents are also anticipated to have an advantageous effect on the Orthopedic Splints market during the forecast period.
Principal Consultant
Compartment syndrome, the creation of pressure sores, and the risk of thermal injuries during the procedure of splinting or casting are among the key growth restraints faced by the Orthopedic Splints market during the forecast period. Moreover, high prices associated with fiberglass splints and the related custom products in some regions around the world may also hamper the growth of the Orthopedic Splints Market during the forecast period. Presently the BSN Medical Articast Fiberglass Casting Tape costs as high as Rs. 1,144 in India. Thus, high costs can be detrimental to the Orthopedic Splints Market.
Asia- Pacific is expected to be the most lucrative region for the Orthopedic Splints Market during the next 10-year epoch owing to the highly accelerated growth it is envisioned to experience. In the recent few years, hip fractures are on a steady rise in Japan, and it is anticipated that hip fractures could go up to 7.3-21.3 million population every year. This is projected to influence the lower extremity segment through the application of the Orthopedic Splints Market in Japan.
A 2018 article by the British Medical Journal states that as many as 135 million Indians are dealing with obesity, which increases the possibility of orthopedic injuries by 48%. As per a NIC report, as many as 467,044 street accidents have been reported in India in 2018 which lead to fractures and related injuries fueling the demand for orthopedic splints in both upper and lower extremities. Moreover, another article by the National Institute of Health and Family (NIHFW), by the Ministry of Health and Welfare (MoHFW) states that not only osteoarthritis is the second most common rheumatologic issue, but it also had a prevalence of 22%-39% in 2018 in the country. All these factors are contributing to the growth of the Orthopedic Splints Market in the country. Since the rise in cases of orthopedic diseases such as osteoarthritis is increasing, it will directly affect the application of orthopedic splints, thereby benefitting the market. The market in the region is further benefitted by the expanding medical tourism, especially to the countries such as India and China due to their comparative cost-effectiveness and availability of high-order equipment.
Orthopedic Splints Market in the North American region accounts for more than 35% of the total market revenue and is projected to keep its dominant position in the market intact during the 10-year forecast period. The USA is forecasted to dominate the Orthopedic Splints Market in the North-American region. Taking into account the World Population Aging Report, people over the age of 65 in the USA and Canada are anticipated to increase from over 60 million in 2019 to approximately 80 million in 2030. Considering the elevated vulnerability of this cohort to arthritis, joint pain, and other related orthopedic conditions, it is anticipated to be instrumental to fuel the growth of the Orthopedic Splints Market forward during the forecasted period of 10 years in the North American region. Additionally, the Orthopedic Splints Market is expected to gain further traction in the North American region from the increasing Sports injuries in the USA The American Academy of Pediatrics reported in a 2019 article that among all the time-loss injuries among soccer players aged 5-17, the most common are ankles and knees, with 20.9% and 16.3% of the total injuries, respectively. Due to this, the demand for orthopedic splints in the lower extremity segment by application is projected to increase during the forecast period, thus positively shaping the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the forthcoming years, the USA is expected to experience a US$ 1.1 billion absolute dollar opportunity to grow at a highly accelerated rate of 12.4% CAGR and reach the market valuation of US$ 1.6 billion by the end of 2032. Centers for Disease Control and Prevention (CDC) estimates that approximately 78 million (26% of the adults in the USA) will be suffering from arthritis by 2040. This increasing volume is set to further fuel the Orthopedic Splints Market during the forecast years.
A recent article by the National Center for Biotechnology Information (NCBI) states that in 2020, approximately 1.5 million people have suffered from fractures related to bone disorders. With as many as 3.5 million annual sports injuries among teens and children in the USA, the demand for orthopedic splints is expected to be benefitted during the forecast period of 10 years due to this, leading to an increase in its application. Thus, the USA is expected to play an instrumental role in the Global Orthopedic Splints Demand in the forthcoming years.
In 2020, around 470,000 workers suffered from work-related musculoskeletal disorders. Considering the overall population, around 20.3 million people in the United Kingdom have musculoskeletal (MSK) conditions such as arthritis or back pain. Apart from this, a large population in the country has been suffering from shin splints. Owing to these facts, the market in the United Kingdom is projected to reach a valuation of US$ 225 million by 2032, growing at a CAGR of 12.4%.
Japan is one of the countries with a high geriatric population. This has kept the Japanese people exposed to several orthopedic ailments. There were nearly 5,000 general hospitals in Japan with orthopedic surgery departments. With these statistics, the orthopedic splints market in Japan is expected to reach a valuation of US$ 194 million by 2032, growing at a CAGR of 11.5% from 2022 to 2032.
A total of 735,073 ankle fractures were identified in 461,497,758 South Korean people in the last 10 years. The annual incidence of ankle fracture was 171.4 per 100,000 persons, with a male-to-female ratio of 0.78. With these statistics, the orthopedic splints market in South Korea is projected to garner an absolute dollar opportunity of US$ 89.2 million, from 2022 to 2032.
Orthopedic Splints market revenue through the lower extremity segment is projected to witness a CAGR of 10.3% during the 10-year epoch. The 2017 statistics of the International Osteoporosis Foundation stated that annually around 8.9 million fractures globally are the result of osteoporosis. This consequently leads to an osteoporosis fracture, every 3 seconds. Over 86% of hip fractures globally occur among the geriatric population. United Nations’ World Population Ageing report of 2019, states that as of 2019, 703 million of the global population is 65 or above. This number is projected to rise to approximately 1.5 billion by 2050. These factors are anticipated to raise the demand for Orthopedic Splints by augmenting their necessity in the Lower Extremity segment during the forecast period.
3M Company, DeRoyal Industries Inc., BSN Medical, Zimmer Biomet Holdings Inc., Medi GmbH & Co. KG, Orthosys, Breg Inc. (Orthofyx), United Medicare, Sam Medical, Essity, Stryker Corporation, DeRoyal Industries Inc., and Ottobock SE & Co. KGaA are among the key players driving the competitive landscape of the market. To expand their product portfolio and simultaneously capitalize on the growing market demand, many of these companies are adopting strategies such as mergers, acquisitions, and partnerships.
Recent Developments
The Orthopedic Splints Market is segmented based on application, product type, end-user, and region.
The Orthopedic Splints market was valued at US$ 1.5 billion in 2021.
The Orthopedic Splints industry is set to witness a growth rate of over 11.5% during the forecast period and be valued at US$ 4.9 billion by 2032.
3M Company, DeRoyal Industries Inc., BSN Medical, Zimmer Biomet Holdings Inc., Medi GmbH & Co. KG, Orthosys, Breg Inc. (Orthofyx), United Medicare, Sam Medical, Essity, Stryker Corporation, DeRoyal Industries Inc., and Ottobock SE & Co. KGaA are among the key players shaping the Orthopedic Splints Industry.
The augmented requirement of orthopedic splints in the lower extremity application due to growing cases of arthritis and other related orthopedic ailments is anticipated to favorably impact the global demand over the forecast period.
The market in the USA is expected to reach a valuation of US$ 1.6 billion by 2032, with a CAGR of 12.4%.
The Asia Pacific market is expected to grow significantly during the forecast period mainly due to the increasing geriatric population leading to a subsequent expansion of the cases of osteoarthritis.
1. Executive Summary | Orthopedic Splints Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.6. Investment Feasibility Matrix
3.7. PESTLE and Porter’s Analysis
3.8. Regulatory Landscape
3.8.1. By Key Regions
3.8.2. By Key Countries
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Plaster Splints
5.3.2. Fiberglass Splints
5.3.3. Tools & Accessories
5.3.4. Other Product Types
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2021
6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2022 to 2032
6.3.1. Upper Extremity
6.3.1.1. Elbow
6.3.1.2. Hand & Wrist
6.3.1.3. Shoulder
6.3.1.4. Neck
6.3.2. Lower Extremity
6.3.2.1. Hip
6.3.2.2. Knee
6.3.2.3. Ankle & Foot
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-user
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) Analysis By End-user, 2017 to 2021
7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End-user, 2022 to 2032
7.3.1. Specialty Centers
7.3.2. Hospitals
7.3.3. Other End-users
7.4. Y-o-Y Growth Trend Analysis By End-user, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End-user, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End-user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End-user
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End-user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End-user
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. The United Kingdom
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End-user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End-user
11.4. Key Takeaways
12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End-user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End-user
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End-user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End-user
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By End-user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End-user
14.4. Key Takeaways
15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. Rest of MEA
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By End-user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End-user
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. The USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Type
16.1.2.2. By Application
16.1.2.3. By End-user
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Type
16.2.2.2. By Application
16.2.2.3. By End-user
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Type
16.3.2.2. By Application
16.3.2.3. By End-user
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Type
16.4.2.2. By Application
16.4.2.3. By End-user
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Type
16.5.2.2. By Application
16.5.2.3. By End-user
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Product Type
16.6.2.2. By Application
16.6.2.3. By End-user
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Product Type
16.7.2.2. By Application
16.7.2.3. By End-user
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Product Type
16.8.2.2. By Application
16.8.2.3. By End-user
16.9. The United Kingdom
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Product Type
16.9.2.2. By Application
16.9.2.3. By End-user
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Product Type
16.10.2.2. By Application
16.10.2.3. By End-user
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Product Type
16.11.2.2. By Application
16.11.2.3. By End-user
16.12. BENELUX
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Product Type
16.12.2.2. By Application
16.12.2.3. By End-user
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Product Type
16.13.2.2. By Application
16.13.2.3. By End-user
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Product Type
16.14.2.2. By Application
16.14.2.3. By End-user
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Product Type
16.15.2.2. By Application
16.15.2.3. By End-user
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Product Type
16.16.2.2. By Application
16.16.2.3. By End-user
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Product Type
16.17.2.2. By Application
16.17.2.3. By End-user
16.18. Malaysia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Product Type
16.18.2.2. By Application
16.18.2.3. By End-user
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Product Type
16.19.2.2. By Application
16.19.2.3. By End-user
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Product Type
16.20.2.2. By Application
16.20.2.3. By End-user
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Product Type
16.21.2.2. By Application
16.21.2.3. By End-user
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2021
16.22.2.1. By Product Type
16.22.2.2. By Application
16.22.2.3. By End-user
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End-user
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. 3M Company
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. DeRoyal Industries Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Zimmer Biomet Holdings Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Medi GmbH & Co. KG
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Orthosys
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Value (US$ million)ed Medicare
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Sam Medical
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. BSN Medical
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments (Product/Region)
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Essity
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments (Product/Region)
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Stryker Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments (Product/Region)
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. DeRoyal Industries Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments (Product/Region)
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Ottobock SE & Co. KGaA
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments (Product/Region)
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Breg Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments (Product/Region)
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Orthopedic Splints Market
